Vertex Pharmaceuticals
@VertexPharma
The official channel for Vertex Pharmaceuticals. https://t.co/RRKBue0r0B
ID:17542775
https://www.vrtx.com/ 21-11-2008 18:52:48
3,5K Tweets
72,2K Followers
89 Following
Today the European Commission approved the label expansion of the first of our four #CysticFibrosis (CF) medicines. This marks an important step towards our goal of treating all people with CF.
At Vertex, we’re inspired by the patients and communities we seek to serve. We’re proud to light up our #Boston building green on #WorldKidneyDay to raise awareness of and show our support for those living with APOL1-mediated #KidneyDisease (AMKD). #NationalKidneyMonth
On #RareDisease Day , our Boston office will be lit in pink, purple, blue and green to represent the 300 million people living with a #RareDisease . Join us in honoring this community and spreading awareness. #ShowYourStripes #ShareYourColours
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the label expansion of the first of our four #CysticFibrosis (CF) medicines. This marks an important step towards our goal of treating all people with CF.
#Breaking The European Commission (EC) approves our treatment for #SickleCellDisease and #BetaThalassemia for the European Union. Learn more: vrtx.com/?utm_source=tw…
Today the Australian Therapeutic Goods Administration (TGA) approved the indication expansion of our fourth #CysticFibrosis (CF) medicine. This marks an important step towards our goal of treating all people with CF.
The Saudi Food and Drug Authority (SFDA) approves our treatment for #SickleCellDisease and #BetaThalassemia in the Kingdom of Saudi Arabia. Learn more: vrtx.com/?utm_source=co…
The EMA’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for our #SickleCellDisease and #BetaThalassemia treatment; an important step in bringing this treatment to patients in the European Union. Learn more: vrtx.com
Today the European Commission approved the label expansion of our fourth #CysticFibrosis (CF) medicine. This marks an important step towards our goal of treating all people with CF.